Aehr Test Systems (NASDAQ:AEHR) Receives $21.00 Average PT from Analysts

Shares of Aehr Test Systems (NASDAQ:AEHR) have been assigned an average rating of “Hold” from the five research firms that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $21.00.

A number of equities research analysts have weighed in on the company. Zacks Research raised Aehr Test Systems from a “strong sell” rating to a “hold” rating in a report on Monday, December 8th. Weiss Ratings reiterated a “sell (d)” rating on shares of Aehr Test Systems in a research report on Wednesday, January 21st. Lake Street Capital started coverage on shares of Aehr Test Systems in a research note on Wednesday, December 17th. They issued a “buy” rating on the stock. Craig Hallum reissued a “hold” rating on shares of Aehr Test Systems in a report on Friday, January 9th. Finally, William Blair raised shares of Aehr Test Systems from a “market perform” rating to an “outperform” rating in a research note on Monday, March 2nd.

Aehr Test Systems Trading Down 12.1%

Shares of AEHR stock opened at $35.61 on Monday. The company has a market capitalization of $1.09 billion, a price-to-earnings ratio of -118.70 and a beta of 2.22. Aehr Test Systems has a 1-year low of $6.27 and a 1-year high of $46.95. The stock’s fifty day simple moving average is $29.17 and its 200-day simple moving average is $26.47.

Aehr Test Systems (NASDAQ:AEHR) last posted its earnings results on Thursday, January 8th. The semiconductor company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.04. Aehr Test Systems had a negative net margin of 16.63% and a negative return on equity of 4.57%. The company had revenue of $9.88 million during the quarter, compared to the consensus estimate of $11.45 million. On average, sell-side analysts predict that Aehr Test Systems will post 0.1 EPS for the current year.

Insider Buying and Selling at Aehr Test Systems

In related news, Director Laura Oliphant sold 4,546 shares of the company’s stock in a transaction dated Thursday, January 22nd. The stock was sold at an average price of $31.40, for a total transaction of $142,744.40. Following the sale, the director owned 18,432 shares in the company, valued at approximately $578,764.80. This represents a 19.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Rhea J. Posedel sold 13,998 shares of the firm’s stock in a transaction on Friday, February 13th. The shares were sold at an average price of $30.02, for a total transaction of $420,219.96. Following the completion of the transaction, the director directly owned 456,979 shares of the company’s stock, valued at $13,718,509.58. This represents a 2.97% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 6.80% of the stock is owned by insiders.

Institutional Investors Weigh In On Aehr Test Systems

Large investors have recently added to or reduced their stakes in the business. Royal Bank of Canada increased its holdings in shares of Aehr Test Systems by 262.7% in the first quarter. Royal Bank of Canada now owns 50,207 shares of the semiconductor company’s stock valued at $365,000 after purchasing an additional 36,364 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Aehr Test Systems by 8.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 17,225 shares of the semiconductor company’s stock valued at $126,000 after purchasing an additional 1,344 shares during the last quarter. CWM LLC increased its stake in shares of Aehr Test Systems by 15.1% during the second quarter. CWM LLC now owns 6,062 shares of the semiconductor company’s stock worth $78,000 after purchasing an additional 793 shares during the period. AlphaQuest LLC lifted its holdings in Aehr Test Systems by 697.6% during the 2nd quarter. AlphaQuest LLC now owns 20,156 shares of the semiconductor company’s stock worth $261,000 after purchasing an additional 17,629 shares during the last quarter. Finally, Geode Capital Management LLC boosted its stake in Aehr Test Systems by 1.3% in the 2nd quarter. Geode Capital Management LLC now owns 678,546 shares of the semiconductor company’s stock valued at $8,775,000 after purchasing an additional 8,658 shares during the period. Institutional investors own 69.69% of the company’s stock.

About Aehr Test Systems

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.